HUMAN PAPILLOMA VIRUS (HPV) QUALITATIVE

Human Papilloma Virus (HPV) Qualitative is an advanced molecular diagnostic test used to detect the presence of Human Papillomavirus (HPV) DNA in clinical specimens. The test utilizes highly sensitive molecular techniques to determine whether HPV infection is present, providing valuable information for screening, diagnosis, and clinical management.

Human Papillomavirus is one of the most common viral infections worldwide and is primarily transmitted through intimate skin-to-skin contact. While many HPV infections resolve naturally without causing symptoms, persistent infection may lead to genital warts, cervical abnormalities, and certain cancers. Early detection plays an important role in preventive healthcare and risk assessment.

Benefits of the Test

• Accurately detects HPV infection.
• Provides highly sensitive molecular results.
• Supports early identification of HPV exposure.
• Useful in cervical cancer screening programs.
• Helps evaluate patients with abnormal cervical findings.
• Supports preventive healthcare and monitoring.
• Provides reliable and accurate diagnostic information.
• Assists healthcare providers in clinical decision-making.

Why Doctors Recommend This Test

Doctors recommend HPV Qualitative testing for women undergoing cervical cancer screening, patients with abnormal Pap smear findings, individuals requiring HPV infection assessment, and those undergoing gynecological evaluation.

The test helps determine whether HPV infection is present and supports appropriate follow-up and clinical management.

Preparation Before Test

• No fasting is required.
• A cervical or genital specimen is typically collected by a healthcare professional.
• Avoid vaginal medications, douches, or intercourse for 24–48 hours before sample collection if advised.
• Inform your doctor about recent gynecological procedures.
• Follow all specimen collection instructions carefully.
• Provide relevant medical history when available.

Normal Reporting Time

Most Human Papilloma Virus (HPV) Qualitative reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final HPV DNA analysis, validation, and reporting are generally completed within a few working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Women undergoing routine cervical cancer screening.
• Patients with abnormal Pap smear results.
• Individuals with suspected HPV infection.
• Women with persistent cervical abnormalities.
• Patients referred by gynecologists.
• Individuals requiring HPV screening.
• People at risk of HPV-related disease.
• Patients requiring molecular confirmation of HPV infection.

Detailed Information

Human Papillomavirus (HPV) is a group of more than 200 related viruses that can infect the skin and mucosal surfaces of the body. Some HPV types cause common warts, while others are associated with genital warts and certain cancers. HPV infection is extremely common, and most sexually active individuals are exposed at some point in their lives.

Most HPV infections are temporary and are cleared naturally by the immune system. However, persistent infection with certain HPV types can lead to abnormal cellular changes, particularly in the cervix. Over time, these changes may progress to precancerous lesions and, in some cases, cervical cancer.

HPV Qualitative testing uses advanced molecular technology to detect HPV DNA directly from patient specimens. Unlike cytology tests that identify cellular changes, HPV testing detects the viral infection itself, allowing earlier identification of individuals who may require monitoring or further evaluation.

The test is commonly used as part of cervical cancer screening programs and may be performed alongside Pap smear testing. Detection of HPV does not indicate cancer but identifies viral infection that may warrant follow-up based on individual risk factors and clinical findings.

Results are reported as positive or negative for HPV DNA. A positive result indicates the presence of HPV genetic material in the specimen. Additional subtype testing may be recommended if high-risk HPV identification is required.

Results should always be interpreted alongside Pap smear findings, clinical examination, colposcopy results, and physician assessment. Appropriate follow-up recommendations depend on age, clinical history, and associated findings.

At Focus Diagnostics, Human Papilloma Virus (HPV) Qualitative testing is performed using advanced molecular diagnostic platforms, validated HPV detection methodologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful screening results.